| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Svlsf Iv, LLC serves as a 10% Owner at OCUL and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 46 sells. Those positions are worth an estimated $2.7M at current prices.
The biggest single holding is KALV (~$1.4M) as 10% Owner. The recent filings there lean toward selling, a net 859,914 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 50,000 | $29.20 | $1,460,145.18 | -51.3% | |
| Apr 2, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 97,074 | $28.03 | $2,720,896.65 | -66.5% | |
| Mar 28, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 124,675 | $28.84 | $3,596,032.22 | -70.8% | |
| Mar 18, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 262,470 | $26.70 | $7,007,949.00 | -82.7% | |
| Mar 5, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 75,710 | $22.96 | $1,738,475.96 | -54.9% | |
| Feb 21, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 214,198 | $20.55 | $4,401,353.41 | -76.9% | |
| Jan 7, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 4,299 | $20.25 | $87,072.89 | -5.8% | |
| Jan 2, 2019 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 29,352 | $20.01 | $587,242.49 | -29.4% | |
| Dec 19, 2018 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Sell | 2,136 | $20.02 | $42,758.45 | -2.9% | |
| Jun 10, 2015 | OCUL Ocular Therapeutix, Inc | 10% Owner | Sell | 1,119,000 | $22.00 | $24,618,000.00 | -94.8% |